NCT06677840View on ClinicalTrials.gov

Exploring the Gut-Brain-Behavior Axis With Biomarkers, Probiotic Efficacy, and Artificial Intelligence Algorithms

NARecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2028

Conditions
Autism Spectrum Disorder
Interventions
OTHER

probiotic (GKB7/placebo)

The objectives of this double-blind randomized placebo-controlled trial are to evaluate the tolerability, safety, and efficacy of the probiotic intervention with Clostridium butyricum GKB7 among 90 4-15-year-old children and adolescents with a clinical diagnosis of ASD according to the DSM-5

Trial Locations (1)

Unknown

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT06677840 - Exploring the Gut-Brain-Behavior Axis With Biomarkers, Probiotic Efficacy, and Artificial Intelligence Algorithms | Biotech Hunter | Biotech Hunter